These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1851375)

  • 1. Autocrine regulation of normal and malignant B lymphocytes.
    Gordon J; Cairns JA
    Adv Cancer Res; 1991; 56():313-34. PubMed ID: 1851375
    [No Abstract]   [Full Text] [Related]  

  • 2. Sample age and Epstein-Barr virus transformation of cryopreserved lymphocytes.
    Reidy JA; Wheeler VA
    In Vitro Cell Dev Biol; 1992 Jun; 28A(6):383-4. PubMed ID: 1321805
    [No Abstract]   [Full Text] [Related]  

  • 3. B-CLL cells experimentally infected with EBV enter DNA synthesis, produce cytokines and stimulate T-lymphocytes.
    Avila-Cariño J; Andersson J; Mellstedt H; Klein E
    Immunol Lett; 1996 Dec; 54(1):45-52. PubMed ID: 9030981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
    Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
    Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lymphocytic leukemia.
    Chiorazzi N; Rai KR; Ferrarini M
    N Engl J Med; 2005 Feb; 352(8):804-15. PubMed ID: 15728813
    [No Abstract]   [Full Text] [Related]  

  • 6. The B cell-immortalizing functions of Epstein-Barr virus.
    Ring CJ
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():1-13. PubMed ID: 8113717
    [No Abstract]   [Full Text] [Related]  

  • 7. The leukemic B-cell population of patients with monoclonal lymphocytosis of undetermined significance (MLUS) are functionally distinct from the chronic lymphocytic leukemia (CLL) derived cell population.
    Aman P; Mellstedt H
    Leuk Res; 1991; 15(8):715-9. PubMed ID: 1654482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved efficiency of EBV transformation of B-lymphocytes.
    Bass H; Darke C
    Cell Prolif; 2004 Dec; 37(6):443-4. PubMed ID: 15548176
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunology. Sinking surveillance's flagship.
    Klein G; Klein E
    Nature; 1998 Oct; 395(6701):441, 443-4. PubMed ID: 9774094
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant CD5 B cells--biased immunoglobulin variable gene usage and autoantibody production.
    Mayer R; Stone K; Han A; Bona C
    Int Rev Immunol; 1991; 7(3):189-203. PubMed ID: 1721931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis.
    Price AM; Luftig MA
    PLoS Pathog; 2015 Mar; 11(3):e1004656. PubMed ID: 25790223
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interleukin-1-like factor from human B-lymphocytes transformed by the Epstein-Barr virus].
    Kotov AIu; Simbirtsev AS; Perumov ND; Ketlinskiĭ SA
    Tsitologiia; 1989 Feb; 31(2):226-33. PubMed ID: 2544049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconsideration of senescence, immortalization and telomere maintenance of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines.
    Sugimoto M; Ide T; Goto M; Furuichi Y
    Mech Ageing Dev; 1999 Feb; 107(1):51-60. PubMed ID: 10197788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors.
    Chen X; Kamranvar SA; Masucci MG
    Oncogene; 2016 Jul; 35(29):3807-16. PubMed ID: 26592445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus and Reed-Sternberg-like cells in chronic lymphocytic leukemia.
    Tsang WY; Chan JK; Ng CS
    Am J Surg Pathol; 1993 Aug; 17(8):853-4. PubMed ID: 8393305
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus.
    Momose H; Jaffe ES; Shin SS; Chen YY; Weiss LM
    Am J Surg Pathol; 1992 Sep; 16(9):859-67. PubMed ID: 1384376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40.
    Crawford DH; Catovsky D
    Immunology; 1993 Sep; 80(1):40-4. PubMed ID: 7503945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
    Wakasugi N; Tagaya Y; Wakasugi H; Mitsui A; Maeda M; Yodoi J; Tursz T
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8282-6. PubMed ID: 2172979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. II. Abortive response of leukemic cells to the transforming virus.
    Takada K; Yamamoto K; Osato T
    Intervirology; 1980; 13(4):223-31. PubMed ID: 6248483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of phorbol esters and cytokines (interleukin-2,-4, and -6) on the proliferation and surface phenotype of Epstein-Barr virus immortalised human B lymphocytes.
    Kosmas C; Epenetos AA; Courtenay-Luck NS
    Leuk Lymphoma; 1992 Sep; 8(1-2):109-15. PubMed ID: 1337296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.